These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2133845)

  • 21. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
    De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
    Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac transplantation: a review.
    Oaks TE; Wallwork J
    Br J Biomed Sci; 1993 Sep; 50(3):200-11. PubMed ID: 8241836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of heart rate changes in cardiac transplant recipients related to graft rejection.
    Heinz G; Laufer G; Ohner T; Gasic S; Laczkovics A
    Am J Cardiol; 1990 Sep; 66(5):647-8. PubMed ID: 2392987
    [No Abstract]   [Full Text] [Related]  

  • 24. HLA-DR matching reduces rejection rate in heart transplantation.
    Leivestad T; Foerster A; Simonsen S; Bratlie A; Thorsby E; Geiran O
    Transpl Int; 1996; 9 Suppl 1():S230-3. PubMed ID: 8959835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor-specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival.
    Irving C; Carter V; Parry G; Hasan A; Kirk R
    Pediatr Transplant; 2011 Mar; 15(2):193-7. PubMed ID: 21199210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse relationship between human leukocyte antigen match and development of coronary artery disease.
    Radovancevic B; Birovljev S; Vega JD; Lonquist JL; Sweeney MS; Vasiljevic JD; Van Buren CT; Kerman RH; Frazier OH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1144-5. PubMed ID: 1989173
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytes.
    Baan CC; Ouwehand AJ; Vaessen LM; Jutte NH; Balk AH; Mochtar B; Claas FH; Weimar W
    Transplant Proc; 1991 Oct; 23(5):2670-1. PubMed ID: 1926527
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation.
    Daly RC; Topilsky Y; Joyce L; Hasin T; Gandhi M; Rosen C; Heimbach J; Edwards BS; Pereira N; Stulak JM; Arendt CJ; Park SJ; Kushwaha SS
    Transplantation; 2013 Jan; 95(2):e2-4. PubMed ID: 23325010
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients.
    Lietz K; John R; Kocher A; Schuster M; Mancini DM; Edwards NM; Itescu S
    Circulation; 2001 Sep; 104(12 Suppl 1):I177-83. PubMed ID: 11568052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood.
    Hendriks GF; van Steenberge EP; Schreuder GM; Wenting GJ; Mochtar B; Bos E; Simoons ML; Balk AH; Laird-Meeter K; Essed CE
    BMJ; 1988 Oct; 297(6653):888-90. PubMed ID: 3140966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation.
    Labarrere CA; Nelson DR; Cox CJ; Pitts D; Kirlin P; Halbrook H
    JAMA; 2000 Jul; 284(4):457-64. PubMed ID: 10904509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term complications of cardiac transplantation.
    Miller LW
    Prog Cardiovasc Dis; 1991; 33(4):229-82. PubMed ID: 1994457
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.
    Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS
    Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The feasibility of HLA matching for lung transplantation.
    McGee C; Fox MD; Loyd JE
    Clin Transplant; 1996 Dec; 10(6 Pt 1):564-7. PubMed ID: 8996780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome.
    Tambur AR; Pamboukian SV; Costanzo MR; Herrera ND; Dunlap S; Montpetit M; Heroux A
    Transplantation; 2005 Oct; 80(8):1019-25. PubMed ID: 16278580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.
    Twito T; Joseph J; Mociornita A; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2011 Jul; 30(7):778-82. PubMed ID: 21482149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.